STAT

STAT+: Roivant says closely watched immune drug succeeded in new eye disease

October 21, 2026

Original source summary

An immune drug from Roivant could be headed to a new market, after the company reported positive trials in the eye disease non-infectious uveitis.

Verbatim from STAT's own feed — "STAT+: Roivant says closely watched immune drug succeeded in new eye disease"

Want more like this?

Browse more from the feed. A free account unlocks the full feed, saving and communities.